The weekly regulatory digest. Key FDA, EMA, MHRA, and PRAC safety actions — summarized, contextualized, and analyzed.
EMA PRAC recommends new contraindication for a widely-used biologic. FDA issues safety communication on GLP-1 receptor agonists and pancreatic safety. WHO releases updated pharmacovigilance guidance for vaccine programs.